NEW YORK (GenomeWeb News) – The National Institute of Allergy and Infectious Diseases plans to grant up to $10.3 million in fiscal 2010 to fund research partnerships focused on developing diagnostics and therapeutics for drug-resistant bacteria and eukaryotic parasites.

NIAID will fund a range of research approaches for NIAID Category A, B, or C bacteria or eukaryotic parasites, as well as development of diagnostics or therapeutics against non-listed organisms for which naturally-occurring drug resistance is a growing clinical problem.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.